drugset / Trial / NCT05597163
Efficacy and Safety of Low-concentration Atropine for Myopia Control in Chinese Children and Adolescents
Unknown
588 enrolled
Shanghai Eye Disease Prevention and Treatment Center
Peking University People's Hospital · collabShandong University of Traditional Chinese Medicine · collabShanghai General Hospital, Shanghai Jiao Tong University School of Medicine · collab
RandomizedParallel-groupDouble-blindTreatment
Summary
To investigate the efficacy and safety of three low-concentration atropine sulfate eye drops (0.01%, 0.025% and 0.05%) in controlling the progression of myopia in Chinese children and adolescents through a two-year clinical trial.
Timeline
- Start
- 2023-01-15
- Primary completion
- 2024-11-01
- Completion
- 2025-11-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Atropine | Other / unclassified | 0.01 % | Other |
| Subject | Atropine | Other / unclassified | 0.025 % | Other |
| Subject | Atropine | Other / unclassified | 0.05 % | Other |